Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma

被引:25
作者
Hashimoto, Kazuhiko [1 ]
Nishimura, Shunji [1 ]
Akagi, Masao [1 ]
机构
[1] Kindai Univ Hosp, Dept Orthoped Surg, 377-2 Ohno Higashi, Osaka 5898511, Japan
关键词
osteosarcoma; PD-1; PD-L1; immune checkpoint pathway; DEATH-LIGAND; 1; PD-L1; CHEMOTHERAPY; PROGRESSION; SURVIVAL; AGE;
D O I
10.3390/diagnostics10080528
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent data have suggested that PD-1 and PD-L1 are involved in osteosarcoma (OS) pathogenesis; however, their contributions are not well-established. Here, the PD-1/PD-L1 expression was evaluated in (OS) cases. Preoperative needle biopsy specimens were obtained from 16 patients with OS. Immunostaining for CD4, CD8, PD-1, and PD-L1 was performed on pathological specimens. Clinical parameters, including age, tumor size, preoperative alkaline phosphatase (ALP) level, standardized uptake value (SUV)-max level, and survival rate, were compared between PD-1/PD-L1-positive and -negative groups. CD4-, CD8-, PD-1-, and PD-L1-positive rates among all specimens were 75%, 75%, 18.7%, and 62.5%, respectively. The rates of co-expression of CD4 and CD8 with PD-L1 were 56.2% and 50%, respectively. Tumors were significantly larger in PD-L1-negative cases than in PD-L1-positive cases. Age, size and ALP and SUV-max levels did not differ significantly between PD-1/PD-L1-positive and -negative cases. The 3-year survival rates did not differ significantly between PD-1-positive and -negative cases or between PD-L1-positive and -negative cases. However, the occurrence of cancer-related events, including recurrence, metastasis, and death was associated with the PD-1-negative and PD-L1-positive status. The PD-1/PD-L1 checkpoint is likely involved in the immune microenvironment in OS and may be involved in the occurrence of cancer-related events.
引用
收藏
页数:10
相关论文
共 26 条
[1]   Signal transduction in the aging immune system [J].
Akha, AAS ;
Miller, RA .
CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (05) :486-491
[2]   Tumor size and prognosis in aggressively treated osteosarcoma [J].
Bieling, P ;
Rehan, N ;
Winkler, P ;
Helmke, K ;
Maas, R ;
Fuchs, N ;
Bielack, S ;
Heise, U ;
Jurgens, H ;
Treuner, J ;
Romanowski, R ;
Exner, U ;
Kotz, R ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :848-858
[3]   PD-1 and PD-L1 Expression in Osteosarcoma: Which Specimen to Evaluate? [J].
Chen, Sonja ;
Guenther, Lillian M. ;
Aronhalt, Amanda ;
Cardillo, Lacey ;
Janeway, Katherine A. ;
Church, Alanna J. .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (08) :482-487
[4]   18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma [J].
Costelloe, Colleen M. ;
Macapinlac, Horner A. ;
Madewell, John E. ;
Fitzgerald, Nancy E. ;
Mawlawi, Osama R. ;
Rohren, Eric M. ;
Raymond, A. Kevin ;
Lewis, Valerae O. ;
Anderson, Peter M. ;
Bassett, Roland L., Jr. ;
Harrell, Robyn K. ;
Marom, Edith M. .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (03) :340-347
[5]   Evaluation of chemotherapy response in osteosarcoma with FDG-PET [J].
Hamada, Kenichiro ;
Tomita, Yasuhiko ;
Inoue, Atsuo ;
Fujimoto, Tetsuho ;
Hashimoto, Nobuyuki ;
Myoui, Akira ;
Yoshikawa, Hideki ;
Hatazawa, Jun .
ANNALS OF NUCLEAR MEDICINE, 2009, 23 (01) :89-95
[6]   Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients [J].
Harting, Matthew T. ;
Lally, Kevin P. ;
Andrassy, Richard J. ;
Vaporciyan, Ara A. ;
Cox, Charles S., Jr. ;
Hayes-Jordan, Andrea ;
Blakely, Martin L. .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (04) :561-570
[7]   Prognostic Value of Programmed Cell Death 1 Ligand-1 (PD-L1) or PD-1 Expression in Patients with Osteosarcoma: A Meta-Analysis [J].
Huang, Xin ;
Zhang, Weiyue ;
Zhang, Zhicai ;
Shi, Deyao ;
Wu, Fashuai ;
Zhong, Binlong ;
Shao, Zengwu .
JOURNAL OF CANCER, 2018, 9 (14) :2525-2531
[8]   Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas [J].
Kim, Jung Ryul ;
Moon, Young Jae ;
Kwon, Keun Sang ;
Bae, Jun Sang ;
Wagle, Sajeev ;
Kim, Kyoung Min ;
Park, Ho Sung ;
Lee, Ho ;
Moon, Woo Sung ;
Chung, Myoung Ja ;
Kang, Myoung Jae ;
Jang, Kyu Yun .
PLOS ONE, 2013, 8 (12)
[9]   Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma [J].
Kim, Seung Hyun ;
Shin, Kyoo-Ho ;
Moon, Seong-Hwan ;
Jang, Jinyoung ;
Kim, Hyo Song ;
Suh, Jin-Suck ;
Yang, Woo-Ick .
CANCER MEDICINE, 2017, 6 (06) :1311-1322
[10]   Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma [J].
Koirala, Pratistha ;
Roth, Michael E. ;
Gill, Jonathan ;
Piperdi, Sajida ;
Chinai, Jordan M. ;
Geller, David S. ;
Hoang, Bang H. ;
Park, Amy ;
Fremed, Michael A. ;
Zang, Xingxing ;
Gorlick, Richard .
SCIENTIFIC REPORTS, 2016, 6